Onderneming Albireo Pharma, Inc.
Aandelen
ALBO
US01345P1066
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 130
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01-06-15 |
Founder | 60 | 08-12-03 | |
President | 57 | 02-03-23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 13-04-21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 19-12-22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 02-03-23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 02-03-23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 04-11-19 |
Muffy Carter
LAW | General Counsel | 71 | 29-11-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 54 | 02-03-23 | |
Director/Board Member | 61 | 02-03-23 | |
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01-06-15 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 20 709 043 | 18 650 831 ( 90,06 %) | 7 760 ( 0,0375 %) | 90,06 % |
Bedrijfsgegevens
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+0,99% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-8,72% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |